BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20677548)

  • 1. Nanotechnology and the Nanodermatology Society.
    Nasir A; Friedman A
    J Drugs Dermatol; 2010 Jul; 9(7):879-82. PubMed ID: 20677548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging applications of nanomedicine in dermatology.
    Saraceno R; Chiricozzi A; Gabellini M; Chimenti S
    Skin Res Technol; 2013 Feb; 19(1):e13-9. PubMed ID: 22175818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanodermatology: a bright glimpse just beyond the horizon - part I.
    Nasir A
    Skin Therapy Lett; 2010 Sep; 15(8):1-4. PubMed ID: 20844848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials.
    Thomas T; Thomas K; Sadrieh N; Savage N; Adair P; Bronaugh R
    Toxicol Sci; 2006 May; 91(1):14-9. PubMed ID: 16476686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology and dermatology: benefits and pitfalls.
    Collins A; Nasir A
    G Ital Dermatol Venereol; 2011 Apr; 146(2):115-26. PubMed ID: 21505397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology and dermatology: part I--potential of nanotechnology.
    Nasir A
    Clin Dermatol; 2010; 28(4):458-66. PubMed ID: 20620764
    [No Abstract]   [Full Text] [Related]  

  • 7. Nanotechnology: are occupational health nurses ready?
    McCauley LA; McCauley RD
    AAOHN J; 2005 Dec; 53(12):517-21. PubMed ID: 16401058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research strategies for safety evaluation of nanomaterials, part VIII: International efforts to develop risk-based safety evaluations for nanomaterials.
    Thomas K; Aguar P; Kawasaki H; Morris J; Nakanishi J; Savage N
    Toxicol Sci; 2006 Jul; 92(1):23-32. PubMed ID: 16687392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology: the coming revolution and its implications for consumers, clinicians, and informatics.
    Staggers N; McCasky T; Brazelton N; Kennedy R
    Nurs Outlook; 2008; 56(5):268-74. PubMed ID: 18922283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanodermatology-based solutions for psoriasis: State-of-the art and future prospects.
    Damiani G; Pacifico A; Linder DM; Pigatto PDM; Conic R; Grada A; Bragazzi NL
    Dermatol Ther; 2019 Nov; 32(6):e13113. PubMed ID: 31600849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplacental transport of nanomaterials.
    Saunders M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(6):671-84. PubMed ID: 20049824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanodermatology: a glimpse of caution just beyond the horizon - part II.
    Nasir A
    Skin Therapy Lett; 2010 Oct; 15(9):4-7. PubMed ID: 20945053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety.
    Nohynek GJ; Lademann J; Ribaud C; Roberts MS
    Crit Rev Toxicol; 2007 Mar; 37(3):251-77. PubMed ID: 17453934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting it right the first time: developing nanotechnology while protecting workers, public health, and the environment.
    Balbus JM; Florini K; Denison RA; Walsh SA
    Ann N Y Acad Sci; 2006 Sep; 1076():331-42. PubMed ID: 17119213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications and implications of nanotechnologies for the food sector.
    Chaudhry Q; Scotter M; Blackburn J; Ross B; Boxall A; Castle L; Aitken R; Watkins R
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Mar; 25(3):241-58. PubMed ID: 18311618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patenting nanotechnology.
    Lemley MA
    Stanford Law Rev; 2005 Nov; 58(2):601-30. PubMed ID: 16395838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
    Fairbrother A; Fairbrother JR
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical methods to assess nanoparticle toxicity.
    Marquis BJ; Love SA; Braun KL; Haynes CL
    Analyst; 2009 Mar; 134(3):425-39. PubMed ID: 19238274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology: the next big thing, or much ado about nothing?
    Maynard AD
    Ann Occup Hyg; 2007 Jan; 51(1):1-12. PubMed ID: 17041243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.